Spatial biology specialist Lunaphore (Tolochenaz, Switzerland) recently announced a collaboration with the pathology department at Massachusetts General Hospital to develop an in vitro diagnostic (IVD) that assesses the sensitivity of solid tumors to poly-ADP ribose polymerase (PARP) inhibitors. “Lunaphore is based on a technology that I developed for my Ph.D. at the Swiss Federal Institute…
Lunaphore and Massachusetts General Hospital partner on spatial biology-based cancer diagnostics
Life sciences company Lunaphore (Lausanne, Switzerland) will collaborate with the Pathology Department at Massachusetts General Hospital to create an in vitro diagnostic (IVD) to evaluate the sensitivity of solid tumors to poly-ADP ribose polymerase (PARP) inhibitors. Lunaphore’s chip technology can extract spatial proteomic and genomic data from tumors. The project will first focus on ovarian,…